Sunzen Biotech to expand TCM business


Sunzen Biotech Teo Yek Ming

KUALA LUMPUR: Maker of animal and human health products, Sunzen Biotech Bhd, is focusing on expanding its traditional Chinese medicine (TCM) business partly by making it more adaptable to the younger segment as it strives for a slice of the RM32bil market.

It also plans to expand the business through leveraging on the boom of the digital marketing platforms during the movement control order (MCO) which began on March 18.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Lagenda eyes next growth chapter with record RM1.75bil unbilled sales
Master Tec posts 21.5% rise in 2Q net profit
DRB-Hicom expects moderate outlook for FY26
OCR’s Residensi Akasia fully sold as project reaches topping-out stage
FGV appoints Nurul Muhaniza Hanafi as group managing director
Golden Destinations eyes growth with East Malaysia, Singapore expansion
ITMAX bags RM186.8mil Perkeso contract
Kossan to acquire S'pore-based company for RM48mil
MMCS eyes growth backed by RM101.7mil order book
Ringgit extends gains to close higher vs major, regional currencies

Others Also Read